Considering the reported EGFR overexpression in 25% to 82% of colorectal cancer cells, it is implied from this evidence and our findings that PEITC, BITC, and SFN might hold promise in cancer treatment by inhibiting the expression of Erb‐B family factors. This evidence concerns the gene EGFR and cancer.